Journal of Lipid Research, Vol 35, 1-9, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

Lipoprotein fractionation in deuterium oxide gradients: a procedure for evaluation of antioxidant binding and susceptibility to oxidation

C Hallberg, M Haden, M Bergstrom, G Hanson, K Pettersson, C Westerlund, G Bondjers, AM Ostlund-Lindqvist and G Camejo
Astra Hassle Preclinical Research Laboratories, Molndal, Sweden.

Oxidative modifications of lipoproteins appear to contribute to their atherogenicity. Very low and low density lipoproteins (VLDL and LDL) are protected against these modifications by antioxidants that can be incorporated in vivo or in vitro into the particles. We describe here ultracentrifugal procedures for isolation of VLDL and LDL that do not require subsequent dialysis or buffer equilibration. Lipoproteins were isolated in buffers with physiological ionic composition prepared in D2O (deuterium oxide). This allowed measurements of the content of antioxidants and of the susceptibility to oxidation of the isolated LDL without further manipulations. Conventional ultracentrifugal methods use high salt concentrations and require additional steps to eliminate them. This introduces uncertainties in the evaluation of antioxidant binding and on measurements of their effect on VLDL and LDL oxidation. With the method described, the composition of the isolated VLDL and LDL was indistinguishable from that of fractions isolated with KBr gradients. Also, the content of alpha-tocopherol was similar. LDL isolated with KBr solutions appeared to bind 20-45% more of the probucol present in serum than LDL isolated in isotonic solutions prepared with D2O. This was the case with probucol incorporated into plasma or serum in vivo or in vitro. Five out of seven LDL isolated with the D2O procedure from different human sera appeared more resistant to Cu(2+)-catalyzed oxidation than those obtained with KBr gradients from the same serum. In addition to the gradient procedure, we also describe a preparative version of the method that can be used with multiple samples.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Stahlman, P. Davidsson, I. Kanmert, B. Rosengren, J. Boren, B. Fagerberg, and G. Camejo Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr J. Lipid Res., February 1, 2008; 49(2): 481 - 490. [Abstract] [Full Text] [PDF]

				P. Davidsson, J. Hulthe, B. Fagerberg, B.-M. Olsson, C. Hallberg, B. Dahllof, and G. Camejo A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes J. Lipid Res., September 1, 2005; 46(9): 1999 - 2006. [Abstract] [Full Text] [PDF]

				F Cardona, F J Tinahones, E Collantes, A Escudero, E Garcia-Fuentes, and F J Soriguer Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout Ann Rheum Dis, January 1, 2005; 64(1): 85 - 88. [Abstract] [Full Text] [PDF]

				P. Sartipy, G. Camejo, L. Svensson, and E. Hurt-Camejo Phospholipase A2 Modification of Low Density Lipoproteins Forms Small High Density Particles with Increased Affinity for Proteoglycans and Glycosaminoglycans J. Biol. Chem., September 3, 1999; 274(36): 25913 - 25920. [Abstract] [Full Text] [PDF]

				G. Camejo, C. Halberg, A. Manschik-Lundin, E. Hurt-Camejo, B. Rosengren, H. Olsson, G. I. Hansson, G.-B. Forsberg, and B. Ylhen Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages J. Lipid Res., April 1, 1998; 39(4): 755 - 766. [Abstract] [Full Text]

				U. Olsson, G. Camejo, E. Hurt-Camejo, K. Elfsber, O. Wiklund, and G. Bondjers Possible Functional Interactions of Apolipoprotein B-100 Segments That Associate With Cell Proteoglycans and the ApoB/E Receptor Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 149 - 155. [Abstract] [Full Text]